La thèse examine les configurations d'acteurs et d'organisations impliquées dans la régulation de l'accès au marché des médicaments en France et en Angleterre, en charge du contrôle scientifique et administratif de la fixation du prix et du remboursement de ces produits. Cette activité s'autonomise de l'appréciation clinique de leur qualité, de leur efficacité et de leur innocuité (dominant la régulation de leur approbation sur le marché) au cours des années 1980.This thesis examines the configurations of actors and organizations involved in the regulation of the market access for drugs in France and England. Since the mid-1980s, this process has entailed the development of administrative and scientific controls over the fixing of the price...
The past few decades have seen the proliferation of regulatory agencies, expert committees, and othe...
Cette thèse se propose d’étudier les déterminants des prix des médicaments innovants de l’oncologie,...
International audienceThis article examines the pricing of reimbursed prescription drugs in France f...
La thèse examine les configurations d'acteurs et d'organisations impliquées dans la régulation de l'...
This thesis examines the configurations of actors and organizations involved in the regulation of th...
When it comes to economic regulation, institutional change has traditionally been examined through t...
International audienceAs in many countries, in France, drug authorization is supposedly carried out ...
This article studies the evolution of drug pricing by the French State since 1948. While the objecti...
A partir de la mesure des élasticités-prix et des élasticités-promotion au sein d'un modèle économét...
Dans l’objectif d’augmenter le bien-être des individus qu’ils représentent, les pouvoirs publics enc...
This article examines how prices for pharmaceuticals reimbursed by the state in France have been det...
This case study aims to provide a better understanding of the necessity for regulation in the market...
The article examines whether and how independent regulatory agencies (IRAs) have altered the strateg...
Price regulation and competition patterns in the ethical drug industry in france This article gives...
Abstract. Drawing on the political theories of corporatism, neo–liberalism and pluralism, and on com...
The past few decades have seen the proliferation of regulatory agencies, expert committees, and othe...
Cette thèse se propose d’étudier les déterminants des prix des médicaments innovants de l’oncologie,...
International audienceThis article examines the pricing of reimbursed prescription drugs in France f...
La thèse examine les configurations d'acteurs et d'organisations impliquées dans la régulation de l'...
This thesis examines the configurations of actors and organizations involved in the regulation of th...
When it comes to economic regulation, institutional change has traditionally been examined through t...
International audienceAs in many countries, in France, drug authorization is supposedly carried out ...
This article studies the evolution of drug pricing by the French State since 1948. While the objecti...
A partir de la mesure des élasticités-prix et des élasticités-promotion au sein d'un modèle économét...
Dans l’objectif d’augmenter le bien-être des individus qu’ils représentent, les pouvoirs publics enc...
This article examines how prices for pharmaceuticals reimbursed by the state in France have been det...
This case study aims to provide a better understanding of the necessity for regulation in the market...
The article examines whether and how independent regulatory agencies (IRAs) have altered the strateg...
Price regulation and competition patterns in the ethical drug industry in france This article gives...
Abstract. Drawing on the political theories of corporatism, neo–liberalism and pluralism, and on com...
The past few decades have seen the proliferation of regulatory agencies, expert committees, and othe...
Cette thèse se propose d’étudier les déterminants des prix des médicaments innovants de l’oncologie,...
International audienceThis article examines the pricing of reimbursed prescription drugs in France f...